Cargando…

Targeting Immune Regulatory Networks to Counteract Immune Suppression in Cancer

The onset of cancer is unavoidably accompanied by suppression of antitumor immunity. This occurs through mechanisms ranging from the progressive accumulation of regulatory immune cells associated with chronic immune stimulation and inflammation, to the expression of immunosuppressive molecules. Some...

Descripción completa

Detalles Bibliográficos
Autores principales:	Camisaschi, Chiara, Vallacchi, Viviana, Vergani, Elisabetta, Tazzari, Marcella, Ferro, Simona, Tuccitto, Alessandra, Kuchuk, Olga, Shahaj, Eriomina, Sulsenti, Roberta, Castelli, Chiara, Rodolfo, Monica, Rivoltini, Licia, Huber, Veronica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5192358/ https://www.ncbi.nlm.nih.gov/pubmed/27827921 http://dx.doi.org/10.3390/vaccines4040038

Ejemplares similares

microRNAs Shape Myeloid Cell-Mediated Resistance to Cancer Immunotherapy
por: Daveri, Elena, et al.
Publicado: (2020)

microRNA Expression in Sentinel Nodes from Progressing Melanoma Patients Identifies Networks Associated with Dysfunctional Immune Response
por: Vallacchi, Viviana, et al.
Publicado: (2016)

pH regulators to target the tumor immune microenvironment in human hepatocellular carcinoma
por: Kuchuk, Olga, et al.
Publicado: (2018)

Complex Immune Contextures Characterise Malignant Peritoneal Mesothelioma: Loss of Adaptive Immunological Signature in the More Aggressive Histological Types
por: Tazzari, Marcella, et al.
Publicado: (2018)

Natural-Killer-Derived Extracellular Vesicles: Immune Sensors and Interactors
por: Federici, Cristina, et al.
Publicado: (2020)

3D tumor explant as a novel platform to investigate therapeutic pathways and predictive biomarkers in cancer patients
por: Rodolfo, Monica, et al.
Publicado: (2022)

miR-146a-5p impairs melanoma resistance to kinase inhibitors by targeting COX2 and regulating NFkB-mediated inflammatory mediators
por: Vergani, Elisabetta, et al.
Publicado: (2020)

Structured myeloid cells and anti-angiogenic therapy in alveolar soft part sarcoma
por: Castelli, Chiara, et al.
Publicado: (2013)

Immune landscape and in vivo immunogenicity of NY-ESO-1 tumor antigen in advanced neuroblastoma patients
por: Camisaschi, Chiara, et al.
Publicado: (2018)

Immune response markers in sentinel nodes may predict melanoma progression
por: Rodolfo, Monica, et al.
Publicado: (2014)

Molecular Determinants of Soft Tissue Sarcoma Immunity: Targets for Immune Intervention
por: Tazzari, Marcella, et al.
Publicado: (2021)

Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b
por: Vergani, Elisabetta, et al.
Publicado: (2015)

Y(90)-radioembolisation in hepatocellular carcinoma induces immune responses calling for early treatment with multiple checkpoint blockers
por: Rivoltini, Licia, et al.
Publicado: (2023)

Melan-A/MART-1 immunity in a EWS-ATF1 translocated clear cell sarcoma patient treated with sunitinib: a case report
por: Tazzari, Marcella, et al.
Publicado: (2015)

3D models for melanoma γδ T cell‐based immunotherapy
por: Huber, Veronica, et al.
Publicado: (2022)

Development of a Molecular Blood-Based Immune Signature Classifier as Biomarker for Risks Assessment in Lung Cancer Screening
por: Fortunato, Orazio, et al.
Publicado: (2022)

Effects of cyclophosphamide and IL-2 on regulatory CD4(+) T cell frequency and function in melanoma patients vaccinated with HLA-class I peptides: impact on the antigen-specific T cell response
por: Camisaschi, Chiara, et al.
Publicado: (2013)

Back to simplicity: a four-marker blood cell score to quantify prognostically relevant myeloid cells in melanoma patients
por: Huber, Veronica, et al.
Publicado: (2021)

Integrated transcriptional‐phenotypic analysis captures systemic immunomodulation following antiangiogenic therapy in renal cell carcinoma patients
por: Rinchai, Darawan, et al.
Publicado: (2021)

Genetic Variants and Somatic Alterations Associated with MITF-E318K Germline Mutation in Melanoma Patients
por: Vergani, Elisabetta, et al.
Publicado: (2021)

Adaptive immune contexture at the tumour site and downmodulation of circulating myeloid-derived suppressor cells in the response of solitary fibrous tumour patients to anti-angiogenic therapy
por: Tazzari, M, et al.
Publicado: (2014)

MIAQuant, a novel system for automatic segmentation, measurement, and localization comparison of different biomarkers from serialized histological slices
por: Casiraghi, Elena, et al.
Publicado: (2017)

A novel computational method for automatic segmentation, quantification and comparative analysis of immunohistochemically labeled tissue sections
por: Casiraghi, Elena, et al.
Publicado: (2018)

More insights into the immunosuppressive potential of tumor exosomes
por: Huber, Veronica, et al.
Publicado: (2008)

Angiogenesis and Immunity in Renal Carcinoma: Can We Turn an Unhappy Relationship into a Happy Marriage?
por: Mennitto, Alessia, et al.
Publicado: (2020)

Metabolism and Immune Modulation in Patients with Solid Tumors: Systematic Review of Preclinical and Clinical Evidence
por: Mirabile, Aurora, et al.
Publicado: (2020)

The acidity of the tumor microenvironment is a mechanism of immune escape that can be overcome by proton pump inhibitors
por: Bellone, Matteo, et al.
Publicado: (2013)

The density and spatial tissue distribution of CD8(+) and CD163(+) immune cells predict response and outcome in melanoma patients receiving MAPK inhibitors
por: Massi, Daniela, et al.
Publicado: (2019)

Fasting-Mimicking Diet Is Safe and Reshapes Metabolism and Antitumor Immunity in Patients with Cancer
por: Vernieri, Claudio, et al.
Publicado: (2022)

Induction of Lymphocyte Apoptosis by Tumor Cell Secretion of FasL-bearing Microvesicles
por: Andreola, Giovanna, et al.
Publicado: (2002)

Probiotic DSF counteracts chemotherapy induced neuropathic pain
por: Castelli, Vanessa, et al.
Publicado: (2018)

Pharmacists as Immunizers: The Role of Pharmacies in Promoting Immunization Campaigns and Counteracting Vaccine Hesitancy
por: Bragazzi, Nicola Luigi
Publicado: (2019)

Preconditioned Mesenchymal Stromal Cell-Derived Extracellular Vesicles (EVs) Counteract Inflammaging
por: Gorgun, Cansu, et al.
Publicado: (2022)

Network modeling of patients' biomolecular profiles for clinical phenotype/outcome prediction
por: Gliozzo, Jessica, et al.
Publicado: (2020)

Bovine Herpesvirus 1 Counteracts Immune Responses and Immune-Surveillance to Enhance Pathogenesis and Virus Transmission
por: Jones, Clinton
Publicado: (2019)

Nanotechnological approaches for counteracting multidrug resistance in cancer
por: Martinelli, Chiara, et al.
Publicado: (2020)

Liquid Biopsy and Radiological Response Predict Outcomes Following Discontinuation of Targeted Therapy in Patients with BRAF Mutated Melanoma
por: Di Guardo, Lorenza, et al.
Publicado: (2021)

PMN-MDSC Frequency Discriminates Active Versus Latent Tuberculosis and Could Play a Role in Counteracting the Immune-Mediated Lung Damage in Active Disease
por: Grassi, Germana, et al.
Publicado: (2021)

A novel CXCR4 antagonist counteracts paradoxical generation of cisplatin-induced pro-metastatic niches in lung cancer
por: Bertolini, Giulia, et al.
Publicado: (2021)

Role of Bacterial Exopolysaccharides as Agents in Counteracting Immune Disorders Induced by Herpes Virus
por: Gugliandolo, Concetta, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qa9u8i8qkgo0krsi8j62cg0kg5